- a Novel Candidate Breast Cancer Susceptibility Locus on 6q14.1

Most non- breast cancer families have no identified genetic cause. We used linkage and haplotype analyses in familial and sporadic breast cancer cases to identify a susceptibility locus on chromosome 6q. Two independent genome-wide linkage analysis studies suggested a 3 Mb locus on chromosome 6q and two unrelated Swedish families with a LOD >2 together seemed to share a haplotype in 6q14.1. We hypothesized that this region harbored a rare high-risk founder allele contributing to breast cancer in these two families. Sequencing of DNA and RNA from the two families did not detect any pathogenic mutations. Finally, 29 SNPs in the region were analyzed in 44,214 cases and 43,532 controls from BCAC, and the original haplotypes in the two families were suggested as low-risk alleles for European and Swedish women specifically. There was also some support for one additional independent moderate-risk allele in Swedish familial samples. The results were consistent with our previous findings in familial breast cancer and supported a breast cancer susceptibility locus at 6q14.1 around the gene.

Citing Articles

WBSCR16 is essential for mitochondrial 16S rRNA processing in mammals.

Zhang S, Dong Z, Feng Y, Guo W, Zhang C, Shi Y Nucleic Acids Res. 2025; 53(3).

PMID: 39878214 PMC: 11775607. DOI: 10.1093/nar/gkae1325.

A Breast Cancer Candidate Locus at 6q Narrowed to 6q15-q21.

Csuka D, Freysteinsdottir E, Johannesdottir G, Agnarsson B, Johannsson O, Barkardottir R Genes (Basel). 2024; 15(2).

PMID: 38397208 PMC: 10888438. DOI: 10.3390/genes15020218.

A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16.

Barnekow E, Liu W, Helgadottir H, Michailidou K, Dennis J, Bryant P Cancers (Basel). 2022; 14(5).

PMID: 35267517 PMC: 8909613. DOI: 10.3390/cancers14051206.

Linkage analysis revealed risk loci on 6p21 and 18p11.2-q11.2 in familial colon and rectal cancer, respectively.

von Holst S, Jiao X, Liu W, Kontham V, Thutkawkorapin J, Ringdahl J Eur J Hum Genet. 2019; 27(8):1286-1295.

PMID: 30952955 PMC: 6777498. DOI: 10.1038/s41431-019-0388-3.

PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.

de Semir D, Bezrookove V, Nosrati M, Dar A, Wu C, Shen J Proc Natl Acad Sci U S A. 2018; 115(25):E5766-E5775.

PMID: 29866840 PMC: 6016792. DOI: 10.1073/pnas.1804779115.

References

Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A . A recurrent mutation in PALB2 in Finnish cancer families. Nature. 2007; 446(7133):316-9. DOI: 10.1038/nature05609. View

Park D, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F . Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet. 2012; 90(4):734-9. PMC: 3322233. DOI: 10.1016/j.ajhg.2012.02.027. View

Hilbers F, Meijers C, Laros J, van Galen M, Hoogerbrugge N, Vasen H . Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling. PLoS One. 2013; 8(1):e55734. PMC: 3561352. DOI: 10.1371/journal.pone.0055734. View

Kruglyak L, Daly M, Lander E . Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996; 58(6):1347-63. PMC: 1915045. View

Marikkannu R, Aravidis C, Rantala J, Picelli S, Adamovic T, Keihas M . Whole-genome Linkage Analysis and Sequence Analysis of Candidate Loci in Familial Breast Cancer. Anticancer Res. 2015; 35(6):3155-65. View

Swift M, Reitnauer P, Morrell D, Chase C . Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med. 1987; 316(21):1289-94. DOI: 10.1056/NEJM198705213162101. View

Lathrop G, Lalouel J, Julier C, Ott J . Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984; 81(11):3443-6. PMC: 345524. DOI: 10.1073/pnas.81.11.3443. View

Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R . Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 2006; 38(11):1239-41. DOI: 10.1038/ng1902. View

Broman K, Murray J, Sheffield V, White R, Weber J . Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet. 1998; 63(3):861-9. PMC: 1377399. DOI: 10.1086/302011. View

10.

Thompson D, Szabo C, Mangion J, Oldenburg R, Odefrey F, Seal S . Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A. 2002; 99(2):827-31. PMC: 117390. DOI: 10.1073/pnas.012584499. View

11.

Schaffer A, Gupta S, Shriram K, Cottingham Jr R . Avoiding recomputation in linkage analysis. Hum Hered. 1994; 44(4):225-37. DOI: 10.1159/000154222. View

12.

Du Q, Luo L, von Wachenfeldt A, Kockum I, Luthman H, Lindblom A . No evidence for a familial breast cancer susceptibility gene at chromosome 13q21 in Swedish breast cancer families. Int J Cancer. 2002; 98(5):799-800. DOI: 10.1002/ijc.10318. View

13.

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

14.

Su Y, Yang J, Tao L, Nguyen H, He P . Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis. J Cancer. 2010; 1:38-50. PMC: 2931353. DOI: 10.7150/jca.1.38. View

15.

Smith P, McGuffog L, Easton D, Mann G, Pupo G, Newman B . A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer. 2006; 45(7):646-55. PMC: 2714969. DOI: 10.1002/gcc.20330. View

16.

Van der Auwera G, Carneiro M, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A . From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2014; 43:11.10.1-11.10.33. PMC: 4243306. DOI: 10.1002/0471250953.bi1110s43. View

17.

Stratton M, Rahman N . The emerging landscape of breast cancer susceptibility. Nat Genet. 2007; 40(1):17-22. DOI: 10.1038/ng.2007.53. View

18.

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

19.

Cottingham Jr R, Idury R, Schaffer A . Faster sequential genetic linkage computations. Am J Hum Genet. 1993; 53(1):252-63. PMC: 1682239. View

20.

Malkin D, Li F, Strong L, Fraumeni Jr J, Nelson C, Kim D . Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990; 250(4985):1233-8. DOI: 10.1126/science.1978757. View